| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
2 |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin)  |
126 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
2 |
4 |
≤0.25 － >32 |
Ceftriaxone (Rocephin) |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
2 |
12 |
? － ? |
Ceftriaxone (Rocephin) |
126 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
4 |
8 |
0.25 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
>4 |
>8 |
? － ? |
Tetracycline (Sumycin, Achromycin V, Steclin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
8 |
12 |
? － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
8 |
12 |
? － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
- |
4 |
8 － ? |
Chloramphenicol (Chloromycetin) |
39 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
0.2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
0.5 － ? |
Tigecycline (GAR-936, Tigacyl) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
1.375 － ? |
Daptomycin (Cubicin) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
1.375 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
1.375 － ? |
Vancomycin (Vancocyn, Lyphocin) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
2.5 － ? |
Quinupristin/Dalfopristin (Synercid) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
3.5 － ? |
Teicoplanin (Targocid) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
<4.02 － ? |
Gentamicin (Gentamycin, Garamycin) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
12 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
901 |
| Staphylococci (coagulase-negative + pork isolate + Korea) |
- |
- |
>128 － ? |
Mupirocin (Bactroban) |
901 |
| Staphylococci (coagulase-negative + quinolone-resistant) |
0.25 |
0.5 |
0.03 － 0.5 |
ABT-492 |
3 |
| Staphylococci (coagulase-negative + quinolone-resistant) |
0.5 |
1 |
? － ? |
WCK-771 |
162 |
| Staphylococci (coagulase-negative + quinolone-resistant) |
0.5 |
1 |
? － ? |
WCK-919 |
162 |
| Staphylococci (coagulase-negative + quinolone-resistant) |
8 |
64 |
4 － 128 |
Levofloxacin (Levaquin, Quixin) |
3 |
| Staphylococci (coagulase-negative + quinolone-resistant) |
- |
0.25 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
162 |
| Staphylococci (coagulase-negative + quinolone-resistant) |
>- |
>128 |
8 － >32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
3 |
| Staphylococci (coagulase-negative + quinolone-susceptible) |
0.015 |
0.03 |
≤0.008 － >4 |
WCK-771 |
162 |
| Staphylococci (coagulase-negative + quinolone-susceptible) |
0.02 |
0.03 |
? － ? |
WCK-919 |
162 |
| Staphylococci (coagulase-negative + quinolone-susceptible) |
0.25 |
0.5 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
162 |
| Staphylococci (coagulase-negative) |
>0.015 |
>2 |
≤0.015 － >2 |
Rifampicin (Rifampin) |
123 |